S3-Leitlinie „Helicobacter pylori und gastroduodenale Ulkuskrankheit” der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS)

" Helicobacter pylori ● " gastroduodenal ulcer ● " ulcer disease Abstract ! This guideline updates a prior concensus re- commendation of the German Society for Diges- tive and Metabolic Diseases (DGVS) from 1996. It was developed by an interdisciplinary coop- eration with representatives of the German So- ciety for Microbiology, the Society for Pediatric Gastroenterology and Nutrition (GPGE) and the German Society for Rheumatology. The guide- line is methodologically based on recommenda- tions of the Association of the Scientific Medical Societies in Germany (AWMF) for providing a systematic evidence-based consensus guideline of S 3 level and has also implemented grading criteria according to GRADE (Grading of Recom- mendations Assessment, Development and Eva- luation). Clinical applicability of study results as well as specifics for Germany in terms of epide- miology, antibiotic resistance status, diagnostics and therapy were taken into account.

[1]  K. Chayama,et al.  Evaluation of Gastric Cancer Risk Using Topography of Histological Gastritis: A Large-scaled Cross-sectional Study , 2008, Digestive Diseases and Sciences.

[2]  M. Stolte,et al.  One‐Week Once‐Daily Triple Therapy with Esomeprazole, Moxifloxacin, and Rifabutin for Eradication of Persistent Helicobacter pylori Resistant to Both Metronidazole and Clarithromycin , 2008, Helicobacter.

[3]  M. Luppi,et al.  Helicobacter pylori infection and chronic immune thrombocytopenic purpura: long-term results of bacterium eradication and association with bacterium virulence profiles. , 2007, Blood.

[4]  He-sheng Luo,et al.  Effects of H pylori therapy on erythrocytic and iron parameters in iron deficiency anemia patients with H pylori-positive chronic gastristis. , 2007, World journal of gastroenterology.

[5]  F. Bazzoli,et al.  Meta-analysis: Duration of First-Line Proton-Pump InhibitorBased Triple Therapy for Helicobacter pylori Eradication , 2007, Annals of Internal Medicine.

[6]  B. Hunt,et al.  Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[7]  M. A. Tkachenko,et al.  Dramatic Changes in the Prevalence of Helicobacter pylori Infection During Childhood: A 10-year Follow-up Study in Russia , 2007, Journal of pediatric gastroenterology and nutrition.

[8]  A. Timmer,et al.  Neue Konzepte der Leitlinienmethodik , 2007 .

[9]  M. Plummer,et al.  Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions. , 2007, Journal of the National Cancer Institute.

[10]  F. Mégraud,et al.  Eradication therapy for Helicobacter pylori. , 2007, Gastroenterology.

[11]  L. Fischbach,et al.  Meta‐analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first‐line therapies for Helicobacter pylori , 2007, Alimentary pharmacology & therapeutics.

[12]  D. Graham,et al.  A Report Card to Grade Helicobacter pylori Therapy , 2007, Helicobacter.

[13]  G. Pizzolo,et al.  Effect of Helicobacter pylori eradication on platelet count in idiopathic thrombocytopenic purpura: a systematic review and meta-analysis. , 2007, The Journal of antimicrobial chemotherapy.

[14]  W. Fischbach,et al.  Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series , 2007, Gut.

[15]  J. Crabtree,et al.  Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. , 2007, Gastroenterology.

[16]  P. Tugwell,et al.  Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[17]  M. Kist.  Helicobacter pylori: primary antimicrobial resistance and first-line treatment strategies. , 2007, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[18]  A. Ferreri,et al.  Primary diffuse large B-cell lymphoma of the stomach. , 2007, Critical reviews in oncology/hematology.

[19]  A. Svennerholm,et al.  Progress in vaccine development against Helicobacter pylori. , 2007, FEMS immunology and medical microbiology.

[20]  C. Hawkey,et al.  Effect of risk factors on complicated and uncomplicated ulcers in the TARGET lumiracoxib outcomes study. , 2007, Gastroenterology.

[21]  E. Steyerberg,et al.  Environmental risk factors in the development of adenocarcinoma of the oesophagus or gastric cardia: a cross‐sectional study in a Dutch cohort , 2007, Alimentary pharmacology & therapeutics.

[22]  C. Hassan,et al.  The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis , 2007, Gut.

[23]  S. Koletzko,et al.  Evaluation of a novel rapid one-step monoclonal chromatographic immunoassay for detection of Helicobacter pylori in stool from children , 2007, European Journal of Clinical Microbiology & Infectious Diseases.

[24]  M. Raderer,et al.  Therapy of gastric mucosa-associated lymphoid tissue lymphoma , 2007, Expert opinion on pharmacotherapy.

[25]  V. Wong,et al.  Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial , 2007, The Lancet.

[26]  A. Barkun,et al.  Antimicrobial Drugs and Community–acquired Clostridium difficile–associated Disease, UK , 2007, Emerging infectious diseases.

[27]  C. Hassan,et al.  Sequential Therapy versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication , 2007, Annals of Internal Medicine.

[28]  F. Mégraud,et al.  Helicobacter pylori Detection and Antimicrobial Susceptibility Testing , 2007, Clinical Microbiology Reviews.

[29]  F. Gottrand,et al.  Results from the Pediatric European Register for Treatment of Helicobacter pylori (PERTH) , 2007, Helicobacter.

[30]  S. Koletzko,et al.  Evaluation of the Novel Helicobacter pylori ClariRes Real-Time PCR Assay for Detection and Clarithromycin Susceptibility Testing of H. pylori in Stool Specimens from Symptomatic Children , 2007, Journal of Clinical Microbiology.

[31]  S. Stewart,et al.  Stress-ulcer prophylaxis for general medical patients: a review of the evidence. , 2007, Journal of hospital medicine.

[32]  P. Sherman,et al.  Meta‐analysis: Helicobacter pylori eradication treatment efficacy in children , 2007, Alimentary pharmacology & therapeutics.

[33]  M. Bellini,et al.  Helicobacter pylori Eradication: A Randomized Prospective Study of Triple Therapy Versus Triple Therapy Plus Lactoferrin and Probiotics , 2007, The American Journal of Gastroenterology.

[34]  P. Malfertheiner,et al.  Treatment and dosing of Helicobacter pylori infection: when pharmacology meets clinic , 2007, Expert opinion on pharmacotherapy.

[35]  M. Kusano,et al.  Differences in the histological findings, phenotypic marker expressions and genetic alterations between adenocarcinoma of the gastric cardia and distal stomach , 2007, British Journal of Cancer.

[36]  B. Tepes.  Comparison of two invasive diagnostic tests for Helicobacter pylori after antimicrobial therapy , 2007, Scandinavian journal of gastroenterology.

[37]  T Rokkas,et al.  Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report , 2006, Gut.

[38]  G. Capurso,et al.  Corpus‐predominant gastritis as a risk factor for false‐negative 13C‐urea breath test results , 2006, Alimentary pharmacology & therapeutics.

[39]  M. Granström,et al.  Comparison of the performance of serological kits for Helicobacter pylori infection with European and Asian study populations. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[40]  E. Ierardi,et al.  Lactobacillus reuteri therapy to reduce side‐effects during anti‐Helicobacter pylori treatment in children: a randomized placebo controlled trial , 2006, Alimentary pharmacology & therapeutics.

[41]  J. Tong,et al.  Meta‐analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy , 2006, Alimentary pharmacology & therapeutics.

[42]  J. Hallas,et al.  Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study , 2006, BMJ : British Medical Journal.

[43]  D. Drossman,et al.  Rome III: New standard for functional gastrointestinal disorders. , 2006, Journal of gastrointestinal and liver diseases : JGLD.

[44]  S. Miehlke,et al.  Effective regimens for the treatment of Helicobacter pylori infection , 2006, Expert opinion on investigational drugs.

[45]  C. Lamers,et al.  The 13carbon urea breath test for the diagnosis of Helicobacter pylori infection in subjects with atrophic gastritis: evaluation in a primary care setting , 2006, Alimentary pharmacology & therapeutics.

[46]  L. Marzio,et al.  Role of the Preliminary Susceptibility Testing for Initial and After Failed Therapy of Helicobacter pylori Infection with Levofloxacin, Amoxicillin, and Esomeprazole , 2006, Helicobacter.

[47]  G. Brandi,et al.  Urease-Positive Bacteria Other than Helicobacter pylori in Human Gastric Juice and Mucosa , 2006, The American Journal of Gastroenterology.

[48]  S. Koletzko,et al.  Esomeprazole-Based 1-Week Triple Therapy Directed by Susceptibility Testing for Eradication of Helicobacter pylori Infection in Children , 2006, Journal of pediatric gastroenterology and nutrition.

[49]  M. Stolte,et al.  Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro‐oesophageal reflux disease in Western patients with non‐ulcer dyspepsia , 2006, Alimentary pharmacology & therapeutics.

[50]  K. Chu,et al.  Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[51]  R. Hunt,et al.  The Effect of CYP2C19 Polymorphisms on H. pylori Eradication Rate in Dual and Triple First-Line PPI Therapies: A Meta-analysis , 2006, The American Journal of Gastroenterology.

[52]  K. Turetschek,et al.  Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[53]  H. Brenner,et al.  Clustering of Helicobacter pylori infection in couples: differences between high- and low-prevalence population groups. , 2006, Annals of epidemiology.

[54]  J. Gisbert,et al.  Accuracy of Monoclonal Stool Antigen Test for the Diagnosis of H. pylori Infection: A Systematic Review and Meta-Analysis , 2006, The American Journal of Gastroenterology.

[55]  C. O'Morain,et al.  In patients with Helicobacter pylori gastritis and functional dyspepsia, a biopsy from the incisura angularis provides useful diagnostic information. , 2006, Pathology, research and practice.

[56]  J. Emberson,et al.  Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials , 2006, BMJ : British Medical Journal.

[57]  F. Mégraud,et al.  Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe , 2006, Gut.

[58]  M. Gotteland,et al.  Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori? , 2006, Alimentary pharmacology & therapeutics.

[59]  S. Lightfoot,et al.  Successful Treatment of Helicobacter Pylori-Negative Gastric MALT Lymphoma With Rituximab , 2006, Digestive Diseases and Sciences.

[60]  Yoshinori Kikuchi,et al.  Influence of urease activity in the intestinal tract on the results of 13C‐urea breath test , 2006, Journal of gastroenterology and hepatology.

[61]  C. Di Lorenzo,et al.  Childhood Functional Gastrointestinal Disorders : Child / Adolescent , 2022 .

[62]  Víctor Abraira,et al.  Accuracy of Helicobacter pylori Diagnostic Tests in Patients with Bleeding Peptic Ulcer: A Systematic Review and Meta-analysis , 2006, The American Journal of Gastroenterology.

[63]  R. Hunt,et al.  Levofloxacin‐based rescue regimens after Helicobacter pylori treatment failure: how strong is the evidence? , 2006, Alimentary pharmacology & therapeutics.

[64]  F. Chan,et al.  Prevention of Ulcers by Esomeprazole in At-Risk Patients Using Non-Selective NSAIDs and COX-2 Inhibitors , 2006, The American Journal of Gastroenterology.

[65]  Mario Plebani,et al.  Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC). , 2006, Journal of the National Cancer Institute.

[66]  E. Waclawski,et al.  Are endoscopy nurses at risk of infection with Helicobacter pylori from their work? , 2006, Occupational medicine.

[67]  Ziding Feng,et al.  A controlled, household-randomized, open-label trial of the effect that treatment of Helicobacter pylori infection has on iron deficiency in children in rural Alaska. , 2006, The Journal of infectious diseases.

[68]  M. Stolte,et al.  Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy – a randomized, double‐blind, placebo‐controlled multicentre trial , 2006, Alimentary pharmacology & therapeutics.

[69]  R. Mahfouz,et al.  Does Helicobacter pylori colonize the nasopharynx of children and contribute to their middle ear disease? , 2006, Acta oto-laryngologica.

[70]  M. Stolte,et al.  Helicobacter pylori eradication in gastric mucosa-associated lymphoid tissue lymphoma: Results of a 196-patient series , 2006, Leukemia & lymphoma.

[71]  J. Gisbert,et al.  Systematic review and meta‐analysis: levofloxacin‐based rescue regimens after Helicobacter pylori treatment failure , 2006, Alimentary pharmacology & therapeutics.

[72]  M. Kivi,et al.  Helicobacter pylori occurrence and transmission: A family affair? , 2006, Scandinavian journal of infectious diseases.

[73]  A. Barkun,et al.  Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. , 2005, JAMA.

[74]  Ken Dewar,et al.  A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. , 2005, The New England journal of medicine.

[75]  A. May,et al.  Capsule endoscopy in gastrointestinal lymphomas. , 2005, Endoscopy.

[76]  L. Laine,et al.  The effect of GI bleeding on Helicobacter pylori diagnostic testing: a prospective study at the time of bleeding and 1 month later. , 2005, Gastrointestinal endoscopy.

[77]  L. T. Álvarez,et al.  Infección por Helicobacter pylori en población infantil: prevalencia, factores asociados e influencia sobre el crecimiento , 2005 .

[78]  U. Jaeger,et al.  Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[79]  A. Chott,et al.  Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas , 2005, Gut.

[80]  M. Asaka,et al.  Randomized study of Helicobacter pylori eradication therapy and proton pump inhibitor monotherapy for idiopathic thrombocytopenic purpura , 2005, Annals of Hematology.

[81]  A. Francavilla,et al.  Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial. , 2005, Gastroenterology.

[82]  M. Stolte,et al.  Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[83]  C. Hawkey,et al.  Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin , 2005, Alimentary pharmacology & therapeutics.

[84]  N. Talley.  American Gastroenterological Association medical position statement: evaluation of dyspepsia. , 2005, Gastroenterology.

[85]  A. Salar,et al.  Persistent residual disease in t(11;18)(q21;q21) positive gastric mucosa-associated lymphoid tissue lymphoma treated with chemotherapy or rituximab. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[86]  J. Gisbert,et al.  Helicobacter pylori“Rescue” Therapy After Failure of Two Eradication Treatments , 2005, Helicobacter.

[87]  N. Willich,et al.  Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[88]  J. J. Tai,et al.  Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. , 2005, Journal of the National Cancer Institute.

[89]  T. Falsafi,et al.  Application of a Stool Antigen Test To Evaluate the Incidence of Helicobacter pylori Infection in Children and Adolescents from Tehran, Iran , 2005, Clinical Diagnostic Laboratory Immunology.

[90]  C. Copie-Bergman,et al.  Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[91]  T. Morizane,et al.  Helicobacter pylori Infection in Dental Professionals: A 6‐year Prospective Study , 2005, Helicobacter.

[92]  H. Matsumoto,et al.  Long‐term clinical outcome of Helicobacter pylori eradication for gastric mucosa‐associated lymphoid tissue lymphoma with a reference to second‐line treatment , 2005, Cancer.

[93]  N. Talley,et al.  The Epidemiology of Childhood Recurrent Abdominal Pain in Western Countries: A Systematic Review , 2005, The American Journal of Gastroenterology.

[94]  M. Struelens,et al.  Prevalence and risk-factors for Helicobacter pylori infection in urban and rural Beninese populations. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[95]  M. Blaser,et al.  Seroprevalence of Helicobacter pylori in New York City populations originating in East Asia , 2005, Journal of Urban Health.

[96]  A. Ozdarendeli,et al.  Detection of Helicobacter pylori in Children with Otitis Media with Effusion: A Preliminary Report , 2005, The Laryngoscope.

[97]  S. Koletzko.  Noninvasive diagnostic tests for Helicobacter pylori infection in children. , 2005, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[98]  O. Nyrén,et al.  Helicobacter pylori Infection and Abdominal Symptoms Among Swedish School Children , 2005, Journal of pediatric gastroenterology and nutrition.

[99]  Robert G. Woodland,et al.  Canadian Helicobacter Study Group Consensus Conference: Update on the approach to Helicobacter pylori infection in children and adolescents--an evidence-based evaluation. , 2005, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[100]  J. Gisbert,et al.  Meta‐analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users , 2005, Alimentary pharmacology & therapeutics.

[101]  T. Mine,et al.  Effect of Helicobacter pylori Eradication in Patients with Chronic Idiopathic Thrombocytopenic Purpura—A Randomized Controlled Trial , 2005, The American Journal of Gastroenterology.

[102]  K. Wada,et al.  Preventive therapy for non‐steroidal anti‐inflammatory drug‐induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled‐study of the preventive effects of lansoprazole or famotidine , 2005, Alimentary pharmacology & therapeutics.

[103]  Z. Şenses,et al.  Is there a relationship between childhood Helicobacter pylori infection and iron deficiency anemia? , 2005, Journal of tropical pediatrics.

[104]  N. Konstantopoulos,et al.  Evaluation of a Novel Rapid One-Step Immunochromatographic Assay for Detection of Monoclonal Helicobacter pylori Antigen in Stool Samples from Children , 2005, Journal of Clinical Microbiology.

[105]  R. Hunt,et al.  Do patients with non-ulcer dyspepsia respond differently to Helicobacter pylori eradication treatments from those with peptic ulcer disease? A systematic review. , 2005, World journal of gastroenterology.

[106]  M. Cattaruzza,et al.  Does hospital work constitute a risk factor for Helicobacter pylori infection? , 2005, Journal of Hospital Infection.

[107]  R. Laheij,et al.  The importance of corpus biopsies for the determination of Helicobacter pylori infection. , 2005, The Netherlands journal of medicine.

[108]  M. Granström,et al.  Long‐term follow‐up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome , 2005, Alimentary pharmacology & therapeutics.

[109]  E. Pedrinis,et al.  Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[110]  M. Reilly,et al.  Helicobacter pylori status in family members as risk factors for infection in children , 2005, Epidemiology and Infection.

[111]  H. Rautelin,et al.  Helicobacter pylori in children who are prone to upper respiratory tract infections. , 2005, Archives of otolaryngology--head & neck surgery.

[112]  R. Tsang,et al.  Radiation therapy for localized low‐grade non‐Hodgkin's lymphomas , 2005, Hematological oncology.

[113]  F. Mégraud.  Comparison of non-invasive tests to detect Helicobacter pylori infection in children and adolescents: results of a multicenter European study. , 2005, The Journal of pediatrics.

[114]  M. Janssen,et al.  Meta‐analysis: the influence of pre‐treatment with a proton pump inhibitor on Helicobacter pylori eradication , 2005, Alimentary pharmacology & therapeutics.

[115]  V. Wong,et al.  Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. , 2005, The New England journal of medicine.

[116]  Nayoung Kim,et al.  Seroconversion of Helicobacter pylori in Korean male employees , 2005, Scandinavian journal of gastroenterology.

[117]  H. Brenner,et al.  Patterns of alcohol consumption and Helicobacter pylori infection: results of a population‐based study from Germany among 6545 adults , 2005, Alimentary pharmacology & therapeutics.

[118]  F. Gottrand,et al.  Helicobacter pylori Infection Is Not Associated With Specific Symptoms in Nonulcer-Dyspeptic Children , 2005, Pediatrics.

[119]  L. Fischbach,et al.  Meta‐analysis: the efficacy, adverse events, and adherence related to first‐line anti‐Helicobacter pylori quadruple therapies , 2004, Alimentary pharmacology & therapeutics.

[120]  J. Gisbert,et al.  Review article: 13C‐urea breath test in the diagnosis of Helicobacter pylori infection – a critical review , 2004, Alimentary pharmacology & therapeutics.

[121]  R. Eliakim,et al.  Comparison of Invasive and Non-Invasive Tests Diagnosis and Monitoring of Helicobacter Pylori Infection in Children , 2004, Journal of pediatric gastroenterology and nutrition.

[122]  J. Houghton,et al.  Molecular biology of gastric cancer: Helicobacter infection and gastric adenocarcinoma: bacterial and host factors responsible for altered growth signaling. , 2004, Gene.

[123]  D. Symmons,et al.  The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review , 2004, BMJ : British Medical Journal.

[124]  I. Kovalszky,et al.  Endoscopic diagnosis of cytomegalovirus infection of upper gastrointestinal tract in solid organ transplant recipients: Hungarian single‐center experience , 2004, Clinical transplantation.

[125]  F. Perna,et al.  Role of Noninvasive Tests (13C‐Urea Breath Test and Stool Antigen Test) as Additional Tools in Diagnosis of Helicobacter Pylori Infection in Patients with Atrophic Body Gastritis , 2004, Helicobacter.

[126]  V. Wong,et al.  Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: results of a randomized double-blind trial. , 2004, Gastroenterology.

[127]  M. Achtman,et al.  Helicobacter pylori: recombination, population structure and human migrations. , 2004, International journal of medical microbiology : IJMM.

[128]  H. Rautelin,et al.  Symptomatic Response to Helicobacter Pylori Eradication in Children With Recurrent Abdominal Pain:: Double Blind Randomized Placebo-controlled Trial , 2004, Journal of clinical gastroenterology.

[129]  A. Chott,et al.  Translocation t(11;18)(q21;q21) Is Not Predictive of Response to Chemotherapy with 2CdA in Patients with Gastric MALT Lymphoma , 2004, Oncology.

[130]  D. Forman,et al.  Eradication Therapy in Helicobacter pylori Positive Peptic Ulcer Disease: Systematic Review and Economic Analysis , 2004, The American Journal of Gastroenterology.

[131]  F. Mégraud.  H pylori antibiotic resistance: prevalence, importance, and advances in testing , 2004, Gut.

[132]  D. Graham,et al.  Challenge model for Helicobacter pylori infection in human volunteers , 2004, Gut.

[133]  P. Malfertheiner,et al.  [Helicobacter pylori infection--an update for 2004]. , 2004, Deutsche medizinische Wochenschrift.

[134]  F. Gottrand,et al.  Acquisition of Helicobacter pylori infection after outbreaks of gastroenteritis: prospective cohort survey in institutionalised young people , 2004, BMJ : British Medical Journal.

[135]  I. Alvarado,et al.  The Role of Surgery in Primary Gastric Lymphoma: Results of a Controlled Clinical Trial , 2004, Annals of surgery.

[136]  M. Boaz,et al.  Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication: comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole , 2004, Alimentary pharmacology & therapeutics.

[137]  U. Klotz,et al.  CYP2C19 polymorphism and proton pump inhibitors. , 2004, Basic & clinical pharmacology & toxicology.

[138]  M. Rafeey,et al.  Relationship between endoscopic nodular gastritis and Helicobacter pylori infection in children. , 2004, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[139]  F. Mégraud,et al.  Identification of a genetic marker of Helicobacter pylori strains involved in gastric extranodal marginal zone B cell lymphoma of the MALT-type , 2004, Gut.

[140]  T. Meyer,et al.  Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers. , 2004, Vaccine.

[141]  M. Vieth,et al.  Reliable detection of macrolide-resistant Helicobacter pylori via fluorescence in situ hybridization in formalin-fixed tissue , 2004, Modern Pathology.

[142]  T. Azuma,et al.  Meta-analysis of the relationship between CagA seropositivity and gastric cancer. , 2004, Gastroenterology.

[143]  M. Janssen,et al.  The influence of pretreatment on cure rates of Helicobacter pylori eradication. , 2004, The Netherlands journal of medicine.

[144]  F. Perna,et al.  Effect of Proton Pump Inhibitors and Antacid Therapy on 13C Urea Breath Tests and Stool Test for Helicobacter Pylori Infection , 2004, American Journal of Gastroenterology.

[145]  N. Yamada,et al.  Topography of chronic active gastritis in Helicobacter pylori-positive Asian populations: age-, gender-, and endoscopic diagnosis-matched study , 2004, Journal of Gastroenterology.

[146]  N. Ukarapol,et al.  Recurrent abdominal pain in children: the utility of upper endoscopy and histopathology. , 2004, Singapore medical journal.

[147]  J. Gisbert,et al.  Helicobacter pylori eradication therapy vs. antisecretory non‐eradication therapy for the prevention of recurrent bleeding from peptic ulcer , 2004 .

[148]  A. Straszak,et al.  Efficacy and Tolerability of Pantoprazole Compared with Misoprostol for the Prevention of NSAID-Related Gastrointestinal Lesions and Symptoms in Rheumatic Patients , 2004, Digestion.

[149]  A. Barkun,et al.  Economic evaluation of Helicobacter pylori eradication in the CADET‐Hp randomized controlled trial of H. pylori‐positive primary care patients with uninvestigated dyspepsia , 2004, Alimentary pharmacology & therapeutics.

[150]  H. Brenner,et al.  Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer? , 2004, American journal of epidemiology.

[151]  Rohit Kohli,et al.  Differential diagnosis of recurrent abdominal pain: new considerations. , 2004, Pediatric annals.

[152]  D. Graham,et al.  False Negative Urea Breath Tests with H2‐Receptor Antagonists: Interactions Between Helicobacter pylori Density and pH , 2004, Helicobacter.

[153]  P. Malfertheiner,et al.  Diagnostics of Helicobacter pylori infection in patients with peptic ulcer bleeding. , 2004, Zeitschrift fur Gastroenterologie.

[154]  D. Forman,et al.  Impact of Helicobacter pylori on society—role for a strategy of ‘search and eradicate’ , 2004, Alimentary pharmacology & therapeutics.

[155]  Justin C.Y. Wu,et al.  Effect of Helicobacter pylori eradication on treatment of gastro-oesophageal reflux disease: a double blind, placebo controlled, randomised trial , 2004, Gut.

[156]  S. Leung,et al.  Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. , 2004, JAMA.

[157]  M. Stolte,et al.  Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series , 2003, Gut.

[158]  E. Kuipers,et al.  GI SNAPSHOT , 2003, Gut.

[159]  L. Engstrand,et al.  Concordance of Helicobacter pylori Strains within Families , 2003, Journal of Clinical Microbiology.

[160]  A. Chott,et al.  Rituximab for Treatment of Advanced Extranodal Marginal Zone B Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Lymphoma , 2003, Oncology.

[161]  P. Unge.  Antimicrobial treatment of H. pylori infection--a pooled efficacy analysis of eradication therapies. , 2003, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.

[162]  R. Tsang,et al.  Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[163]  P. Malfertheiner,et al.  European multicentre validation trial of two new non‐invasive tests for the detection of  Helicobacter pylori antibodies: urine‐based ELISA and rapid urine test , 2003, Alimentary pharmacology & therapeutics.

[164]  R. Corrêa-Oliveira,et al.  Transmission of Helicobacter pylori infection in families of preschool‐aged children from Minas Gerais, Brazil , 2003, Tropical medicine & international health : TM & IH.

[165]  F. Cavalli,et al.  Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. , 2003, Blood.

[166]  J. Gisbert,et al.  Meta‐analysis: proton pump inhibitors vs. H2‐receptor antagonists — their efficacy with antibiotics in Helicobacter pylori eradication , 2003, Alimentary pharmacology & therapeutics.

[167]  R. Hunt,et al.  Multilaboratory Comparison of Proficiencies in Susceptibility Testing of Helicobacter pylori and Correlation between Agar Dilution and E Test Methods , 2003, Antimicrobial Agents and Chemotherapy.

[168]  K. Chu,et al.  Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti‐inflammatory drug users – a randomized trial , 2003, Alimentary pharmacology & therapeutics.

[169]  O. Hosokawa,et al.  Remission of severe anemia persisting for over 20 years after eradication of Helicobacter pylori in cases of Ménètrier's disease and atrophic gastritis: Helicobacter pylori as a pathogenic factor in iron-deficiency anemia. , 2003, Internal medicine.

[170]  F. Perna,et al.  Susceptibility of Helicobacter pylori to metronidazole , 2003, American Journal of Gastroenterology.

[171]  Chia‐Long Lee,et al.  Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study. , 2003, Archives of internal medicine.

[172]  L. Cohen,et al.  Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia , 2003, American Journal of Gastroenterology.

[173]  P. Malfertheiner,et al.  Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia , 2003, Alimentary pharmacology & therapeutics.

[174]  M. Vieth,et al.  A Prospective, Randomized Study of Quadruple Therapy and High‐Dose Dual Therapy for Treatment of Helicobacter Pylori Resistant to Both Metronidazole and Clarithromycin , 2003, Helicobacter.

[175]  O. P. Mishra,et al.  Helicobacter pylori infection and recurrent abdominal pain in children. , 2003, Journal of tropical pediatrics.

[176]  K. Haruma,et al.  The long‐term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis , 2003, Alimentary pharmacology & therapeutics.

[177]  R. Marmo,et al.  Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori. , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[178]  D. de Jong,et al.  Paris staging system for primary gastrointestinal lymphomas , 2003, Gut.

[179]  P. Malfertheiner,et al.  What constitutes failure for Helicobacter pylori eradication therapy? , 2003, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[180]  N. Konstantopoulos,et al.  Evaluation of a novel monoclonal enzyme immunoassay for detection of Helicobacter pylori antigen in stool from children , 2003, Gut.

[181]  X. Calvet,et al.  Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta‐analysis , 2003, Alimentary pharmacology & therapeutics.

[182]  D. Graham,et al.  Meta‐analysis: proton pump inhibitor or H2‐receptor antagonist for Helicobacter pylori eradication , 2003, Alimentary pharmacology & therapeutics.

[183]  D. Graham,et al.  Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors , 2003, American Journal of Gastroenterology.

[184]  H. Brenner,et al.  Recurrent abdominal pain in children: evidence from a population-based study that social and familial factors play a major role but not Helicobacter pylori infection. , 2003, Journal of psychosomatic research.

[185]  J. Gisbert,et al.  Triple vs. quadruple therapy for treating Helicobacter pylori infection: an updated meta‐analysis , 2003, Alimentary pharmacology & therapeutics.

[186]  D. Schilling,et al.  A negative rapid urease test is unreliable for exclusion of Helicobacter pylori infection during acute phase of ulcer bleeding. A prospective case control study. , 2003, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[187]  G. Amann,et al.  Helicobacter pylori in Children and Adolescents: Increase of Primary Clarithromycin Resistance, 1997–2000 , 2003, Journal of pediatric gastroenterology and nutrition.

[188]  W. Hui,et al.  Effect of treatment of Helicobacter pylori on the prevention of gastroduodenal ulcers in patients receiving long‐term NSAIDs: a double‐blind, placebo‐controlled trial , 2003, Alimentary pharmacology & therapeutics.

[189]  F. Mégraud,et al.  Which Test to Use to Detect Helicobacter pylori Infection in Patients With Low-Grade Gastric Mucosa-Associated Lymphoid Tissue Lymphoma? , 2003, American Journal of Gastroenterology.

[190]  T. D. da Silveira,et al.  Endoscopic Nodular Gastritis: An Endoscopic Indicator of High-Grade Bacterial Colonization and Severe Gastritis in Children With Helicobacter pylori , 2003, Journal of pediatric gastroenterology and nutrition.

[191]  D. Aust,et al.  Detection of Helicobacter pylori in Paraffin-Embedded and in Shock-Frozen Gastric Biopsy Samples by Fluorescent In Situ Hybridization , 2003, Journal of Clinical Microbiology.

[192]  G. Losonsky,et al.  B cell responses in gastric antrum and duodenum following oral inactivated Helicobacter pylori whole cell (HWC) vaccine and LT(R192G) in H pylori seronegative individuals. , 2003, Vaccine.

[193]  G. Alfvén.  One hundred cases of recurrent abdominal pain in children: diagnostic procedures and criteria for a psychosomatic diagnosis , 2003, Acta paediatrica.

[194]  V. Wong,et al.  Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. , 2002, The New England journal of medicine.

[195]  L. Laine,et al.  Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies , 2002, American Journal of Gastroenterology.

[196]  D. Roder,et al.  The epidemiology of gastric cancer , 2002, Gastric Cancer.

[197]  S. Koletzko,et al.  Fluorescence in situ hybridization vs. epsilometer test for detection of clarithromycin‐susceptible and clarithromycin‐resistant Helicobacter pylori strains in gastric biopsies from children , 2002, Alimentary pharmacology & therapeutics.

[198]  T. Monath,et al.  Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers , 2002, Gut.

[199]  L. Hutwagner,et al.  Seroincidence of Helicobacter pylori infection in a cohort of rural Bolivian children: acquisition and analysis of possible risk factors. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[200]  Diz-Lois Palomares Mt,et al.  Early-stage gastric MALT lymphomas: eradication of H. pylori and outcome. , 2002 .

[201]  C. O'Morain,et al.  Does Helicobacter pylori Eradication Affect Symptoms in Nonulcer Dyspepsia: A 5‐Year Follow‐Up Study , 2002, Helicobacter.

[202]  N. Konstantopoulos,et al.  Reinfection rate in children after successful Helicobacter pylori eradication , 2002, European journal of gastroenterology & hepatology.

[203]  M. Stolte,et al.  Features of gastritis predisposing to gastric adenoma and early gastric cancer , 2002, Journal of clinical pathology.

[204]  R. Brezinschek,et al.  Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[205]  A. Blum,et al.  Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial , 2002, Gut.

[206]  H. Müller-Hermelink,et al.  Minimal residual low-grade gastric MALT-type lymphoma after eradication of Helicobacter pylori , 2002, The Lancet.

[207]  M. Stolte,et al.  Close correlation of intestinal metaplasia and corpus gastritis in patients infected with Helicobacter pylori. , 2002, Zeitschrift fur Gastroenterologie.

[208]  P. Malfertheiner,et al.  Antibiotic susceptibility of Helicobacter pylori in Germany: stable primary resistance from 1995 to 2000. , 2002, Journal of medical microbiology.

[209]  P. Malfertheiner,et al.  Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease — results from a randomized trial programme , 2002, Alimentary pharmacology & therapeutics.

[210]  Norikazu Yoshimura,et al.  Diagnostic accuracy of the 13C-urea breath test for childhood Helicobacter pylori infection: a multicenter Japanese study , 2002, American Journal of Gastroenterology.

[211]  E. Kuipers,et al.  Genotyping of Helicobacter pylori in paraffin-embedded gastric biopsy specimens: relation to histological parameters and effects on therapy , 2002, American Journal of Gastroenterology.

[212]  H. Brenner,et al.  Role of infected parents in transmission of Helicobacter pylori to their children , 2002, The Pediatric infectious disease journal.

[213]  K. Chu,et al.  Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. , 2002, The New England journal of medicine.

[214]  M. Becker,et al.  13C-Urea breath test threshold calculation and evaluation for the detection of Helicobacter pylori infection in children , 2002, BMC gastroenterology.

[215]  M. Stolte,et al.  Helicobacter and gastric MALT lymphoma , 2002, Gut.

[216]  Á. Lanas,et al.  Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low‐dose aspirin , 2002, Alimentary pharmacology & therapeutics.

[217]  J. Atherton,et al.  Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding , 2002, Alimentary pharmacology & therapeutics.

[218]  K. Goodman,et al.  Isolation and Genotyping of Helicobacter pylori from Untreated Municipal Wastewater , 2002, Applied and Environmental Microbiology.

[219]  P. Strisciuglio,et al.  Antral Nodularity and Positive CagA Serology are Distinct and Relevant Markers of Severe Gastric Inflammation in Children with Helicobacter pylori Infection , 2002, Helicobacter.

[220]  T. Celkan,et al.  Radiological features in paediatric primary gastric MALT lymphoma and association with Helicobacter pylori , 2002, Pediatric Radiology.

[221]  U. Klotz,et al.  Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study). , 2002, Archives of internal medicine.

[222]  D. Graham,et al.  Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole. , 2002, Archives of internal medicine.

[223]  B. E. C. Oiffier,et al.  CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma , 2002 .

[224]  Justin C.Y. Wu,et al.  Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial , 2002, The Lancet.

[225]  P. Malfertheiner,et al.  [Insufficient validity of a rapid blood test for diagnosis of Helicobacter pylori infection]. , 2001, Medizinische Klinik.

[226]  D. Fan,et al.  Association of H. pylori infection with gastric carcinoma: a Meta analysis. , 2001, World journal of gastroenterology.

[227]  T. Meyer,et al.  Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers. , 2001, Vaccine.

[228]  Ross D. Shachter,et al.  Quantifying the population impact of a prophylactic Helicobacter pylori vaccine. , 2001, Vaccine.

[229]  A. Sahai,et al.  Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage , 2001, Alimentary pharmacology & therapeutics.

[230]  P. Malfertheiner,et al.  A meta‐analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori‐associated gastric or duodenal ulcer , 2001, Alimentary pharmacology & therapeutics.

[231]  T. Molina,et al.  T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. , 2001, Gastroenterology.

[232]  A. Cheng,et al.  Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[233]  B. Drumm,et al.  Limitations to carbon 13-labeled urea breath testing for Helicobacter pylori in infants. , 2001, The Journal of pediatrics.

[234]  A. Axon,et al.  Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. , 2001, Gastroenterology.

[235]  M. Färkkilä,et al.  Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia , 2001, American Journal of Gastroenterology.

[236]  O. Herbarth,et al.  Five- to 7-Year-Old Children With Helicobacter pylori Infection Are Smaller Than Helicobacter-Negative Children: A Cross-Sectional Population-Based Study of 3,315 Children , 2001, Journal of pediatric gastroenterology and nutrition.

[237]  L. Hansson,et al.  Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. , 2001, Gastroenterology.

[238]  N. Willich,et al.  Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma--results of the prospective German Multicenter Study GIT NHL 01/92. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[239]  S. Koletzko,et al.  Infants differ from teenagers: use of non-invasive tests for detection of Helicobacter pylori infection in children , 2001, European journal of gastroenterology & hepatology.

[240]  A. Helicobacter,et al.  Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts , 2001, Gut.

[241]  A. Pærregaard,et al.  Treatment of Helicobacter pylori in Children With Recurrent Abdominal Pain , 2001, Helicobacter.

[242]  F. Granath,et al.  Helicobacter pylori infection in Swedish school children: lack of evidence of child-to-child transmission outside the family. , 2001, Gastroenterology.

[243]  B. Burnand,et al.  Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia , 2001, American Journal of Gastroenterology.

[244]  B. Burnand,et al.  Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia. , 2001 .

[245]  A. Mäkipernaa,et al.  Helicobacter pylori and Iron Deficiency Anaemia in Children , 2001, Scandinavian journal of gastroenterology.

[246]  C. Dupont,et al.  Clarithromycin Resistance and Eradication ofHelicobacter pylori in Children , 2001, Antimicrobial Agents and Chemotherapy.

[247]  G. Losonsky,et al.  Safety and Immunogenicity of Oral Inactivated Whole-CellHelicobacter pylori Vaccine with Adjuvant among Volunteers with or without Subclinical Infection , 2001, Infection and Immunity.

[248]  M. Seto,et al.  API2-MALT1 chimeric transcript is a predictive marker for the responsiveness of H. pylori eradication treatment in low-grade gastric MALT lymphoma. , 2001, Gastroenterology.

[249]  N. Konstantopoulos,et al.  Control your controls and conclusions , 2001, Archives of disease in childhood.

[250]  D. Graham,et al.  Isolation of helicobacter pylori from sheep—implications for transmission to humans , 2001, American Journal of Gastroenterology.

[251]  H. Müller-Hermelink,et al.  Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[252]  F. Chan,et al.  Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. , 2001, The New England journal of medicine.

[253]  M. Stolte,et al.  Long-term persistence of monoclonal B cells after cure of Helicobacter pylori infection and complete histologic remission in gastric mucosa-associated lymphoid tissue B-cell lymphoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[254]  N. Konstantopoulos,et al.  Evaluation of the Helicobacter pylori stool antigen test (HpSA) for detection of Helicobacter pylori infection in children , 2001, American Journal of Gastroenterology.

[255]  T. Molina,et al.  Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pyloritreatment , 2001, Gut.

[256]  M. Luppi,et al.  Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. , 2001, Blood.

[257]  M. Stolte,et al.  Diagnostic Accuracy of 13C-Urea Breath Test in the Diagnosis of Helicobacter pylori Infection in Patients with Partial Gastric Resection due to Peptic Ulcer Disease , 2001, Digestion.

[258]  Ming-Qing Du,et al.  Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy , 2001, The Lancet.

[259]  David B. Schauer,et al.  Emergence of Diverse HelicobacterSpecies in the Pathogenesis of Gastric and Enterohepatic Diseases , 2001, Clinical Microbiology Reviews.

[260]  C. Dupont,et al.  High Levels of Resistance to Metronidazole and Clarithromycin in Helicobacter pylori Strains in Children , 2001, Journal of Clinical Microbiology.

[261]  G. Manes,et al.  Accuracy of the stool antigen test in the diagnosis of Helicobacter pylori infection before treatment and in patients on omeprazole therapy , 2001, Alimentary pharmacology & therapeutics.

[262]  A. Ferreri,et al.  Prognostic Significance of the Histopathologic Recognition of Low-and High-Grade Components in Stage I-II B-Cell Gastric Lymphomas , 2001, The American journal of surgical pathology.

[263]  M. Stolte,et al.  Gastric polyps: an update of their pathology and biological significance , 2000, Virchows Archiv.

[264]  R Day,et al.  Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. , 2000, The New England journal of medicine.

[265]  J. Burnie,et al.  An association between sudden infant death syndrome (SIDS) andHelicobacter pylori infection , 2000, Archives of disease in childhood.

[266]  H. Müller-Hermelink,et al.  Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group. , 2000, Gastroenterology.

[267]  T. Stallmach,et al.  Helicobacter pylori Infection in Recurrent Abdominal Pain , 2000, Journal of pediatric gastroenterology and nutrition.

[268]  S. Bhakdi,et al.  Helicobacter pylori: Clonal Population Structure and Restricted Transmission within Families Revealed by Molecular Typing , 2000, Journal of Clinical Microbiology.

[269]  M. Dyer,et al.  BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma. , 2000, The American journal of pathology.

[270]  P. Apfalter,et al.  Two Enzyme Immunoassays and PCR for Detection ofHelicobacter pylori in Stool Specimens from Pediatric Patients before and after Eradication Therapy , 2000, Journal of Clinical Microbiology.

[271]  R. Makuch,et al.  Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. , 2000, JAMA.

[272]  N. York,et al.  Treating H. pylori shorter than one week - a real future perspective? , 2000, Zeitschrift fur Gastroenterologie.

[273]  M. Stolte,et al.  Malignant tumors of the stomach. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori. , 2000, Gastroenterology clinics of North America.

[274]  P. Malfertheiner,et al.  The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany , 2000, International journal of cancer.

[275]  S. Hernández-Díaz,et al.  Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. , 2000, Archives of internal medicine.

[276]  L. Hansson,et al.  Decreasing incidence of both major histologic subtypes of gastric adenocarcinoma – a population-based study in Sweden , 2000, British Journal of Cancer.

[277]  A. Wolk,et al.  Dietary antioxidant intake and the risk of cardia cancer and noncardia cancer of the intestinal and diffuse types: A population‐based case‐control study in Sweden , 2000, International journal of cancer.

[278]  J. Sung,et al.  Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. , 2000, Gastroenterology.

[279]  A. Verbeek,et al.  Diagnostic performance of biopsy-based methods for determination of Helicobacter pylori infection without a reference standard. , 2000, Journal of clinical epidemiology.

[280]  P. Marynen,et al.  Translocation t(11;18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication of Helicobacter pylori infection. , 2000, Blood.

[281]  Y. Ni,et al.  Accurate diagnosis of Helicobacter pylori infection by stool antigen test and 6 other currently available tests in children. , 2000, The Journal of pediatrics.

[282]  Kamada,et al.  High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis , 2000, Alimentary pharmacology & therapeutics.

[283]  Gené,et al.  A meta‐analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection , 2000, Alimentary pharmacology & therapeutics.

[284]  E. Kuipers,et al.  EVect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy , 2000 .

[285]  M. Stolte,et al.  Helicobacter heilmannii-associated primary gastric low-grade MALT lymphoma: complete remission after curing the infection. , 2000, Gastroenterology.

[286]  G. Rocha,et al.  Immunoblot Analysis of Humoral Immune Response to Helicobacter pylori in Children with and without Duodenal Ulcer , 2000, Journal of Clinical Microbiology.

[287]  C. O'Morain,et al.  Rapid urease tests lack sensitivity in Helicobacter pylori diagnosis when peptic ulcer disease presents with bleeding , 2000, American Journal of Gastroenterology.

[288]  E. Hohmann,et al.  Pilot Study of phoP/phoQ-DeletedSalmonella enterica Serovar Typhimurium ExpressingHelicobacter pylori Urease in Adult Volunteers , 2000, Infection and Immunity.

[289]  P. Marynen,et al.  The product of the t(11;18), an API2-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation. , 2000, The American journal of pathology.

[290]  J. Yahalom,et al.  Low-grade MALT lymphoma of the stomach: a review of treatment options. , 2000, International journal of radiation oncology, biology, physics.

[291]  M. Seto,et al.  Helicobacter pylori and the t(11;18)(q21;q21) Translocation in Gastric Low‐grade B‐Cell Lymphoma of Mucosa‐associated Lymphoid Tissue Type , 2000, Japanese journal of cancer research : Gann.

[292]  A. Andriulli,et al.  Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. , 2000, The New England journal of medicine.

[293]  D. Graham,et al.  Therapy of Helicobacter pylori: current status and issues. , 2000, Gastroenterology.

[294]  J. Lee,et al.  Effect of Helicobacter pylori eradication on sideropenic refractory anaemia in adolescent girls with Helicobacter pylori infection , 2000, Acta paediatrica.

[295]  S. Koletzko,et al.  helicobacter pylori Infection in Children: A Consensus Statement , 2000 .

[296]  M. Färkkilä,et al.  Diagnosis of Helicobacter pylori Infection in Patients with Atrophic Gastritis: Comparison of Histology, 13C-Urea Breath Test, and Serology , 2000, Scandinavian journal of gastroenterology.

[297]  C. Dupont,et al.  Immunoblotting and serology for diagnosis of Helicobacter pylori infection in children , 2000, The Pediatric infectious disease journal.

[298]  P. Correa,et al.  Transmission of Helicobacter pylori among siblings , 2000, The Lancet.

[299]  M. Rawlins,et al.  Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs , 2000, Gut.

[300]  Vakil,et al.  Recurrent symptoms and gastro‐oesophageal reflux disease in patients with duodenal ulcer treated for Helicobacter pylori infection , 2000, Alimentary pharmacology & therapeutics.

[301]  T. Haggerty,et al.  Fecal and oral shedding of Helicobacter pylori from healthy infected adults. , 1999, JAMA.

[302]  L. Hansson,et al.  Occupational exposures and risk of gastric cancer in a population-based case-control study. , 1999, Cancer research.

[303]  Ross D. Shachter,et al.  Helicobacter pylori Vaccine Development and Use: A Cost‐Effectiveness Analysis Using the Institute of Medicine Methodology , 1999, Helicobacter.

[304]  S. Bhakdi,et al.  One-step polymerase chain reaction-based typing of Helicobacter pylori vacA gene: association with gastric histopathology , 1999, Medical Microbiology and Immunology.

[305]  G Flandrin,et al.  The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[306]  R. Spiller,et al.  Antimicrobial Susceptibility Testing ofHelicobacter pylori in a Large Multicenter Trial: the MACH 2 Study , 1999, Antimicrobial Agents and Chemotherapy.

[307]  K. Killeen,et al.  Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers. , 1999, Vaccine.

[308]  N. Talley,et al.  Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. , 1999, The New England journal of medicine.

[309]  J. Sung,et al.  Isolation of Helicobacter pylori from vomitus in children and its implication in gastro-oral transmission , 1999, American Journal of Gastroenterology.

[310]  C. Macarthur,et al.  Helicobacter pylori and childhood recurrent abdominal pain: community based case-control study , 1999, BMJ.

[311]  D. Graham,et al.  Normalizing results of 13C-urea breath testing for CO2 production rates in children. , 1999, Journal of pediatric gastroenterology and nutrition.

[312]  F. Gottrand,et al.  Natural Outcome of Helicobacter pylori Infection in Asymptomatic Children: A Two-year Follow-up Study , 1999, Pediatrics.

[313]  P. Malfertheiner,et al.  Validity of a modified 13C-urea breath test for pre- and posttreatment diagnosis of Helicobacter pylori infection in the routine clinical setting , 1999, American Journal of Gastroenterology.

[314]  L. Daly,et al.  Low rates of Helicobacter pylori reinfection in children. , 1999, Gastroenterology.

[315]  L. Lundell,et al.  Lack of effect of acid suppression therapy on gastric atrophy. Nordic Gerd Study Group. , 1999, Gastroenterology.

[316]  K. Goodman,et al.  Age distribution of Helicobacter pylori seroprevalence among young children in a United States/Mexico border community: evidence for transitory infection. , 1999, American journal of epidemiology.

[317]  Jeffrey E. Lee,et al.  Antibiotic Treatment of Gastric Lymphoma of Mucosa-Associated Lymphoid Tissue: An Uncontrolled Trial , 1999, Annals of Internal Medicine.

[318]  D. Graham,et al.  Helicobacter pylori in sheep milk , 1999, The Lancet.

[319]  M. Stolte,et al.  Helicobacter pylori gastritis of the gastric cancer phenotype in relatives of gastric carcinoma patients. , 1999, European journal of gastroenterology & hepatology.

[320]  Danesh.  Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies , 1999, Alimentary pharmacology & therapeutics.

[321]  F. Roudot-thoraval,et al.  Seroprevalence of eight Helicobacter pylori antigens among 182 patients with peptic ulcer, MALT gastric lymphoma or non-ulcer dyspepsia. Higher rate of seroreactivity against CagA and 35-kDa antigens in patients with peptic ulcer originating from Europe and Africa. , 1999, European journal of gastroenterology & hepatology.

[322]  H. Straatman,et al.  Evaluation of treatment regimens to cure Helicobacter pylori infection—a meta‐analysis , 1999, Alimentary pharmacology & therapeutics.

[323]  S. Kim,et al.  Randomized Placebo‐Controlled Trial of Helicobacter pylori Eradication for Iron‐Deficiency Anemia in Preadolescent Children and Adolescents , 1999, Helicobacter.

[324]  R. Hunt,et al.  The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta‐analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole , 1999, Alimentary pharmacology & therapeutics.

[325]  R. Spiller,et al.  The GU‐MACH study: the effect of 1‐week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer , 1999, Alimentary pharmacology & therapeutics.

[326]  R. Holder,et al.  Helicobacter pylori-associated antibodies in patients with duodenal ulcer, gastric and oesophageal adenocarcinoma. , 1999, European journal of gastroenterology & hepatology.

[327]  Axon,et al.  The optimal antibiotic combination in a 5‐day Helicobacter pylori eradication regimen , 1999, Alimentary pharmacology & therapeutics.

[328]  A. Sonnenberg,et al.  The effect of antibiotic therapy on bleeding from duodenal ulcer , 1999, American Journal of Gastroenterology.

[329]  A. Blum,et al.  Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. , 1999, Gastroenterology.

[330]  D. Graham,et al.  Costs of diagnosis and treatment of Helicobacter pylori infection: when does choosing the treatment regimen based on susceptibility testing become cost effective? , 1999, American Journal of Gastroenterology.

[331]  G. Porro,et al.  Is routine histological evaluation an accurate test for Helicobacter pylori infection? , 1999, Alimentary pharmacology & therapeutics.

[332]  J. de Korwin,et al.  Evaluation of a New Serologic Test for Diagnosis of Helicobacter pylori Infection in Children , 1999, European Journal of Clinical Microbiology and Infectious Diseases.

[333]  R. Spiller,et al.  The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. , 1999, Gastroenterology.

[334]  E. Mendes,et al.  Evaluation of enzyme-linked immunosorbent assay for the diagnosis of Helicobacter pylori infection in children from different age groups with and without duodenal ulcer. , 1999, Journal of pediatric gastroenterology and nutrition.

[335]  R. Knill-Jones,et al.  Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. , 1998, The New England journal of medicine.

[336]  A. Blum,et al.  Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. , 1998, The New England journal of medicine.

[337]  Pohle,et al.  Eradication of Helicobacter pylori with lansoprazole, roxithromycin and metronidazole—an open pilot study , 1998, Alimentary pharmacology & therapeutics.

[338]  L. Laine,et al.  Effect of Proton-Pump Inhibitor Therapy on Diagnostic Testing for Helicobacter pylori , 1998, Annals of Internal Medicine.

[339]  Á. Lanas,et al.  Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study , 1998, The Lancet.

[340]  V. Diehl,et al.  Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study. , 1998, Blood.

[341]  L. Corvaglia,et al.  Detection of Helicobacter pylori infection in children with a standardized and simplified 13C-urea breath test. , 1998, Journal of pediatric gastroenterology and nutrition.

[342]  L. Laine,et al.  Has the impact of helicobacter pylori therapy on ulcer recurrence in the united states been overstated? , 1998, American Journal of Gastroenterology.

[343]  H. Nagai,et al.  Helicobacter pylori infection induces gastric cancer in mongolian gerbils. , 1998, Gastroenterology.

[344]  P. Malfertheiner,et al.  Performance of a Rapid Whole Blood Test for Helicobacter pylori in Primary Care: A German Multicenter Study , 1998, Helicobacter.

[345]  D. Graham,et al.  Acquisition versus loss of Helicobacter pylori infection in Japan: results from an 8-year birth cohort study. , 1998, The Journal of infectious diseases.

[346]  D. Palli,et al.  Short stature and Helicobacter pylori infection in Italian children: prospective multicentre hospital based case-control study , 1998, BMJ.

[347]  J. Lambert,et al.  The impact of Helicobacter pylori eradication on peptic ulcer healing , 1998, American Journal of Gastroenterology.

[348]  P. Malfertheiner,et al.  Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori. , 1998, British Journal of Cancer.

[349]  R. Hunt,et al.  Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. , 1998, Gastroenterology.

[350]  J. Yahalom,et al.  Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[351]  H. Brenner,et al.  Helicobacter pylori and Abdominal Symptoms: A Population-based Study Among Preschool Children in Southern Germany , 1998, Pediatrics.

[352]  J. Holton,et al.  Helicobacter pylori and diminished growth in children: is it simply a marker of deprivation? , 1998, Italian journal of gastroenterology and hepatology.

[353]  D. Rothenbacher,et al.  Prevalence and determinants of Helicobacter pylori infection in preschool children: a population-based study from Germany. , 1998, International journal of epidemiology.

[354]  R. Hopkins.  Current FDA-approved treatments for Helicobacter pylori and the FDA approval process. , 1997, Gastroenterology.

[355]  S. Mönig,et al.  Treatment and prognosis of gastric lymphoma. , 1997, The European journal of surgery = Acta chirurgica.

[356]  T. Greiner,et al.  t(11;18)(q21;q21) is the most common translocation in MALT lymphomas. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[357]  B. Braden,et al.  Endoscopy is not a risk factor for Helicobacter pylori infection--but medical practice is. , 1997, Gastrointestinal endoscopy.

[358]  M. Stolte,et al.  Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group. , 1997, Gastroenterology.

[359]  M. Fujishima,et al.  Ménétrièr's disease associated with Helicobacter pylori infection: resolution of enlarged gastric folds and hypoproteinemia after antibacterial treatment. , 1997, The American journal of gastroenterology.

[360]  M. Stolte,et al.  Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. , 1997, Journal of the National Cancer Institute.

[361]  A. Rosenwald,et al.  The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. , 1997, Cancer research.

[362]  E. Kuipers,et al.  Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. , 1997, The American journal of gastroenterology.

[363]  Mark Borodovsky,et al.  The complete genome sequence of the gastric pathogen Helicobacter pylori , 1997, Nature.

[364]  A. Blum,et al.  Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. , 1997, Gastroenterology.

[365]  W. Chey,et al.  Lansoprazole and ranitidine affect the accuracy of the 14C-urea breath test by a pH-dependent mechanism. , 1997, The American journal of gastroenterology.

[366]  T. Hori,et al.  Resolution of protein-losing hypertrophic gastropathy by eradication of Helicobacter pylori , 1997, European Journal of Pediatrics.

[367]  J. L. Taylor,et al.  Pharmacoeconomic comparison of treatments for the eradication of Helicobacter pylori. , 1997, Archives of internal medicine.

[368]  D. Graham,et al.  The Best Gastric Site for Obtaining a Positive Rapid Urease Test , 1996, Helicobacter.

[369]  S. Shapiro,et al.  Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product , 1996, The Lancet.

[370]  A. Karrenbeld,et al.  Diagnostic tests for Helicobacter pylori: a prospective evaluation of their accuracy, without selecting a single test as the gold standard. , 1996, The American journal of gastroenterology.

[371]  M F Dixon,et al.  Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. , 1996, The American journal of surgical pathology.

[372]  J. Hyams,et al.  Abdominal pain and irritable bowel syndrome in adolescents: a community-based study. , 1996, The Journal of pediatrics.

[373]  J. DeLany,et al.  Helicobacter pylori infection in the Colombian Andes: a population-based study of transmission pathways. , 1996, American journal of epidemiology.

[374]  S. Hill,et al.  Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis , 1996, BMJ.

[375]  L. Irwig,et al.  Do commercial serological kits for Helicobacter pylori infection differ in accuracy? A meta-analysis. , 1996, The American journal of gastroenterology.

[376]  J. V. D. van der Meer,et al.  Value of laboratory investigations in clinical suspicion of cytomegalovirus‐induced upper gastrointestinal tract ulcerations in HIV‐infected patients , 1996, Journal of medical virology.

[377]  D. Graham,et al.  Helicobacter pylori in the drinking water in Peru. , 1996, Gastroenterology.

[378]  M. Guslandi,et al.  Symptomatic response to omeprazole in inflammatory bowel disease. , 1996, Journal of clinical gastroenterology.

[379]  G. Treiber.  The influence of drug dosage on Helicobacter pylori eradication: a cost-effectiveness analysis. , 1996, The American journal of gastroenterology.

[380]  J. Hallas,et al.  Non-steroidal anti-inflammatory drugs and ulcer complications: a risk factor analysis for clinical decision-making. , 1996, Scandinavian journal of gastroenterology.

[381]  D. Graham,et al.  Prevalence of Helicobacter pylori infection in Korean children: inverse relation to socioeconomic status despite a uniformly high prevalence in adults. , 1996, American journal of epidemiology.

[382]  G. Guyatt,et al.  Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. , 1996, JAMA.

[383]  C. Macarthur,et al.  Helicobacter pylori, gastroduodenal disease, and recurrent abdominal pain in children. , 1995, JAMA.

[384]  M. Stolte,et al.  Recurrence of duodenal ulcers during five years of follow-up after cure of Helicobacter pylori infection , 1995, European journal of gastroenterology & hepatology.

[385]  J. Slattery,et al.  Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin--analysis of gastrointestinal bleeding during the UK-TIA trial. , 1995, Gut.

[386]  P. Gaulard,et al.  Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[387]  D. Jong,et al.  Role of Helicobacter pylori eradication in high-grade MALT lymphoma , 1995, The Lancet.

[388]  M. Blaser,et al.  Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. , 1995, Gastroenterology.

[389]  M. Stolte,et al.  Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection , 1995, The Lancet.

[390]  F. Cavalli,et al.  Eradication of Helicobacter pylori Infection in Primary Low-Grade Gastric Lymphoma of Mucosa-Associated Lymphoid Tissue , 1995, Annals of Internal Medicine.

[391]  J. Deeks,et al.  Multi-laboratory comparison of eight commercially availableHelicobacter pylori serology kits , 1995, European Journal of Clinical Microbiology and Infectious Diseases.

[392]  M. Rawlins,et al.  Prophylactic aspirin and risk of peptic ulcer bleeding , 1995, BMJ.

[393]  M. Stolte,et al.  Relationships between the degree of Helicobacter pylori colonisation and the degree and activity of gastritis, surface epithelial degeneration and mucus secretion. , 1995, Zeitschrift fur Gastroenterologie.

[394]  A. Ferguson,et al.  Successful Helicobacter pylori eradication incorporating a one‐week antibiotic regimen , 1995, Alimentary pharmacology & therapeutics.

[395]  M. Schubert,et al.  Helicobacter pylori and gastric lymphoma. , 1995, Gastroenterology.

[396]  H Stein,et al.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.

[397]  D. Graham,et al.  Helicobacter pylori: consensus reached: peptic ulcer is on the way to becoming an historic disease. , 1994, The American journal of gastroenterology.

[398]  Fred E. Silverstein,et al.  Helicobacter pylori in peptic ulcer disease. , 1994, NIH consensus statement.

[399]  C. O'Morain,et al.  Helicobacter pylori Infection , 1994 .

[400]  P. Chyou,et al.  Helicobacter pylori Infection and the Risk for Duodenal and Gastric Ulceration , 1994, Annals of Internal Medicine.

[401]  D. Graham,et al.  Helicobacter pylori Infection: Genetic and Environmental Influences: A Study of Twins , 1994, Annals of Internal Medicine.

[402]  J. Dickinson,et al.  Is omeprazole helpful in inflammatory bowel disease? , 1994, Journal of clinical gastroenterology.

[403]  H. Goto,et al.  A proposed staging system for primary gastric lymphoma , 1994, Cancer.

[404]  F. Dewhirst,et al.  Helicobacter pylori isolated from the domestic cat: public health implications , 1994, Infection and immunity.

[405]  R. Warnke,et al.  Helicobacter pylori infection and gastric lymphoma. , 1994, The New England journal of medicine.

[406]  M. Stolte,et al.  Healing of protein losing hypertrophic gastropathy by eradication of Helicobacter pylori--is Helicobacter pylori a pathogenic factor in Ménétrier's disease? , 1994, Gut.

[407]  G. Guyatt,et al.  Risk factors for gastrointestinal bleeding in critically ill patients , 1994 .

[408]  I. Ng,et al.  Cytomegalovirus infection of the gastrointestinal tract in non-AIDS patients. , 1993, The American journal of gastroenterology.

[409]  P. Isaacson,et al.  The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori , 1993, The Lancet.

[410]  F. Mégraud,et al.  The cohort effect and Helicobacter pylori. , 1993, The Journal of infectious diseases.

[411]  R. Hunt,et al.  Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. , 1992, The American journal of gastroenterology.

[412]  D. Graham,et al.  Helicobacter pylori in Hispanics: comparison with blacks and whites of similar age and socioeconomic class. , 1992, Gastroenterology.

[413]  T. Radaszkiewicz,et al.  Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis. , 1992, Gastroenterology.

[414]  D. Strachan,et al.  Childhood living conditions and Helicobacter pylori seropositivity in adult life , 1992, The Lancet.

[415]  C. Doglioni,et al.  High incidence of primary gastric lymphoma in northeastern Italy , 1992, The Lancet.

[416]  M. Stolte,et al.  Helicobacter pylori gastritis and gastric MALT-lymphoma , 1992, The Lancet.

[417]  D. Rattner,et al.  Fulminant peptic ulcer disease in cardiac surgical patients: Pathogenesis, prevention, and management , 1992, Critical care medicine.

[418]  P. Isaacson,et al.  Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma , 1991, The Lancet.

[419]  G. Friedman,et al.  Helicobacter pylori infection and the risk of gastric carcinoma. , 1991, The New England journal of medicine.

[420]  D. Graham,et al.  Seroepidemiology ofHelicobacter pylori infection in India , 1991, Digestive Diseases and Sciences.

[421]  D. Graham,et al.  Water source as risk factor for Helicobacter pylori infection in Peruvian children , 1991, The Lancet.

[422]  Alter Mj,et al.  Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. , 1991, BMJ.

[423]  D. Forman,et al.  Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China , 1990, International journal of cancer.

[424]  D. Graham,et al.  Prevalence of Helicobacter (formerly Campylobacter) pylori infection in Saudia Arabia, and comparison of those with and without upper gastrointestinal symptoms. , 1990, The American journal of gastroenterology.

[425]  M. Stolte,et al.  Lymphoid follicles in antral mucosa: immune response to Campylobacter pylori? , 1989, Journal of clinical pathology.

[426]  STRESS ULCER PROPHYLAXIS IN CRITICALLY ILL PATIENTS , 1989, The Lancet.

[427]  M. Stolte,et al.  Topographic association between active gastritis and Campylobacter pylori colonisation. , 1989, Journal of clinical pathology.

[428]  F. Mégraud,et al.  Seroepidemiology of Campylobacter pylori infection in various populations , 1989, Journal of clinical microbiology.

[429]  D. Stringer,et al.  Peptic ulcer disease in children: etiology, clinical findings, and clinical course. , 1988, Pediatrics.

[430]  P. Isaacson,et al.  Primary B‐cell gastric lymphoma—a reassessment of its histogenesis , 1987, The Journal of pathology.

[431]  P. Isaacson,et al.  Malignant lymphoma of mucosa‐associated lymphoid tissue , 1987, Histopathology.

[432]  R. Summers,et al.  National Cooperative Crohn's Disease Study: results of drug treatment. , 1979, Gastroenterology.

[433]  A. Schutt,et al.  Primary gastric malignant lymphoma followed by gastric adenocarcinoma. Report of 4 cases and review of the literature , 1978, Cancer.

[434]  D. Ettinger,et al.  Gastric carcinoma 16 years after gastric lymphoma irradiation. , 1977, The American journal of gastroenterology.

[435]  F. Foley,et al.  Curling??s ulcer: a clinical-pathology study of 323 cases , 1971 .

[436]  F. Foley,et al.  Curling's Ulcer: A Clinical‐Pathology Study of 323 Cases , 1970, Annals of surgery.

[437]  J APLEY,et al.  Recurrent Abdominal Pains: A Field Survey of 1,000 School Children , 1958, Archives of disease in childhood.

[438]  Thomas K. Hunt,et al.  ON THE TREATMENT OF , 1846 .

[439]  L. Daly,et al.  Age-specific incidence of Helicobacter pylori. , 2006, Gastroenterology.

[440]  D. Forman,et al.  Eradication of Helicobacter pylori for non-ulcer dyspepsia. , 2006, The Cochrane database of systematic reviews.

[441]  A. Bossuyt,et al.  The early effect of proton pump inhibitor therapy on the accuracy of the 13C-urea breath test. , 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[442]  T. Ishizaki,et al.  Influence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies. , 2005, Drug metabolism and pharmacokinetics.

[443]  L. Torroba Álvarez,et al.  [Helicobacter pylori infection in the child population in Spain: prevalence, related factors and influence on growth]. , 2005, Anales de pediatria.

[444]  D. de Jong,et al.  Interobserver variation in the histopathological assessment of malt/malt lymphoma: towards a consensus. , 2005, Blood cells, molecules & diseases.

[445]  J. Gisbert,et al.  Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer. , 2004, Alimentary pharmacology & therapeutics.

[446]  D. Forman,et al.  Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. , 2006, The Cochrane database of systematic reviews.

[447]  W. Fischbach,et al.  [Helicobacter pylori infection in children and juveniles: an epidemiological study on prevalence, socio-economic factors and symptoms]. , 2003, Deutsche medizinische Wochenschrift.

[448]  D. Forman,et al.  Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. , 2004, The Cochrane database of systematic reviews.

[449]  F. Mégraud,et al.  Validation of diffusion methods for macrolide susceptibility testing of Helicobacter pylori. , 2002, Microbial drug resistance.

[450]  Pierre Morel,et al.  CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. , 2002, The New England journal of medicine.

[451]  J. Y. Yáñez López,et al.  Early-stage gastric MALT lymphomas: eradication of H. pylori and outcome. , 2002, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[452]  A. Soweid,et al.  Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori. , 2002, Gastrointestinal endoscopy.

[453]  M. Stolte,et al.  Diagnostic accuracy of (13)C-urea breath test in the diagnosis of Helicobacter pylori infection in patients with partial gastric resection due to peptic ulcer disease: a prospective multicenter study. , 2001, Digestion.

[454]  N. Konstantopoulos,et al.  Evaluation of Two Commercial Enzyme Immunoassays, Testing Immunoglobulin G (IgG) and IgA Responses, for Diagnosis of Helicobacter pylori Infection in Children , 2001 .

[455]  B. Koletzko,et al.  Influence of age on 13C-urea breath test results in children. , 2000, Journal of pediatric gastroenterology and nutrition.

[456]  M. Stolte,et al.  Lack of effect of acid suppression therapy on gastric atrophy. , 2000, Gastroenterology.

[457]  Lise,et al.  Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. , 2000, The New England journal of medicine.

[458]  A. Scarpa,et al.  Relapse of low-grade gastric MALT lymphoma after Helicobacter pylori eradication: true relapse or persistence? Long-term post-treatment follow-up of a multicenter trial in the north-east of Italy and evaluation of the diagnostic protocol's adequacy. , 2000, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[459]  濱田 博重.  High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori : Impacts of hiatal hernia and corpus gastritis , 2000 .

[460]  J. Spivak,et al.  Commentary on and reprint of Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG, Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma, in Lancet (1991) 338:1175–1176 , 2000 .

[461]  J. Kleibeuker,et al.  The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: a meta-analysis , 1999, American Journal of Gastroenterology.

[462]  J. Byles,et al.  Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis , 1999, American Journal of Gastroenterology.

[463]  A. Barabino,et al.  Unexplained refractory iron-deficiency anemia associated with Helicobacter pylori gastric infection in children: further clinical evidence. , 1999, Journal of pediatric gastroenterology and nutrition.

[464]  T. Hirayama,et al.  Divergence of virulence factors of Helicobacter pylori among clinical isolates does not correlate with disease specificity. , 1999, Journal of gastroenterology.

[465]  C. Hawkey,et al.  Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention. , 1998, Lancet.

[466]  Y. Kodera,et al.  The role of radical gastrectomy with systematic lymphadenectomy for the diagnosis and treatment of primary gastric lymphoma. , 1998, Annals of surgery.

[467]  R. Hunt,et al.  Guidelines for clinical trials in Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group. , 1997, Gut.

[468]  G. Stevenson,et al.  Infection with Helicobacter pylori. , 1996, AJR. American journal of roentgenology.

[469]  M. Brennan,et al.  Long-term follow-up after curative surgery for early gastric lymphoma. , 1996, Annals of surgery.

[470]  W. Opferkuch,et al.  Cure of Helicobacter pylori infection: role of duration of treatment with omeprazole and amoxicillin. , 1996, The American journal of gastroenterology.

[471]  J. Parsonnet.  The incidence of Helicobacter pylori infection. , 1995, Alimentary pharmacology & therapeutics.

[472]  J. Deeks,et al.  Multi-laboratory comparison of eight commercially available Helicobacter pylori serology kits. Helicobacter pylori Serology Study Group. , 1995, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.

[473]  M. Stolte,et al.  Helicobacter heilmannii (formerly Gastrospirillum hominis) gastritis: an infection transmitted by animals? , 1994, Scandinavian journal of gastroenterology.

[474]  NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. , 1994, JAMA.

[475]  G. Bell,et al.  Helicobacter pylori eradication. , 1993, The Practitioner.

[476]  K. Ewe,et al.  European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. , 1984, Gastroenterology.

[477]  T. Wasserman,et al.  Non-Hodgkin's lymphoma of the stomach. , 1983, The American journal of gastroenterology.

[478]  K. Musshoff.  Klinische Stadieneinteilung der Nicht-Hodgkin lymphome , 1977 .

[479]  M. Staneva,et al.  [Ménétrier's disease]. , 1975, Khirurgiia.